 |
Yigal Stav, M.Sc. Chief Executive Officer
Mr. Yigal Stav has a 20-year track record as one of the most successful CEOs in Israel. Yigal holds a M.Sc. degree in Physics, a B.Sc. degree in Mathematics and Physics and a MBA degree. |
|
 |
Muli Ben-sasson, PhD. Scientific founder
Prof. Ben-Sasson of the Dept. of Experimental Medicine & Cancer Research, The Hebrew University-Hadassah Medical School, Jerusalem, also held for ten years a position of a Visiting Professor at the Harvard Medical School, in affiliation with the lab of the world leader in the field of tumor angiogenesis, Prof. Judah Folkman. |
|
 |
Dan Goldstaub, PhD. Chief Operating Officer
Dr. Dan Goldstaub holds a PhD in Molecular Genetics from the Weizmann Inst. Of Science and has over 12 years experience in drug development, including heading the Multiple-Sclerosis Clinical Program of Teva Pharmaceuticals Innovative R&D Division. At this capacity, was responsible for Teva's largest clinical program, including Copaxone® and other products in various stages of development. |
|
